Eversept Partners as of Sept. 30, 2022
Portfolio Holdings for Eversept Partners
Eversept Partners holds 63 positions in its portfolio as reported in the September 2022 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ) | 18.1 | $209M | 782k | 267.26 | |
GSK Sponsored Ad (GSK) | 13.0 | $149M | 5.0M | 29.69 | |
Biohaven Pharmaceutical Holding | 8.3 | $96M | 637k | 151.17 | |
Horizon Therapeutics Pub L SHS | 6.8 | $79M | 1.3M | 61.89 | |
Natera (NTRA) | 5.4 | $63M | 1.4M | 43.82 | |
United Therapeutics Corporation (UTHR) | 4.6 | $53M | 255k | 209.38 | |
Danaher Corporation (DHR) | 3.6 | $42M | 163k | 258.54 | |
Biogen Idec (BIIB) | 3.4 | $39M | 147k | 267.00 | |
Sanofi Sponsored Adr (SNY) | 3.3 | $38M | 996k | 38.02 | |
Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 3.0 | $35M | 4.3M | 8.07 | |
Syndax Pharmaceuticals (SNDX) | 2.5 | $29M | 1.2M | 24.03 | |
Envista Hldgs Corp (NVST) | 1.8 | $21M | 633k | 32.81 | |
Illumina (ILMN) | 1.8 | $20M | 107k | 190.79 | |
Community Health Systems (CYH) | 1.6 | $19M | 8.8M | 2.15 | |
Celldex Therapeutics Com New (CLDX) | 1.5 | $18M | 626k | 28.11 | |
Spdr Ser Tr S&p Biotech (XBI) | 1.3 | $15M | 190k | 79.32 | |
Anthem (ELV) | 1.3 | $15M | 33k | 454.24 | |
Centene Corporation (CNC) | 1.3 | $15M | 191k | 77.81 | |
Lantheus Holdings Inc Common Stock Usd 0.01 (LNTH) | 1.3 | $15M | 207k | 70.33 | |
Amarin Corp Spons Adr New (AMRN) | 1.1 | $13M | 12M | 1.09 | |
Abiomed | 1.1 | $13M | 53k | 245.66 | |
Seres Therapeutics (MCRB) | 1.1 | $12M | 1.9M | 6.42 | |
Humana (HUM) | 1.0 | $12M | 25k | 485.96 | |
Miragen Therapeutics (VRDN) | 0.9 | $9.8M | 478k | 20.51 | |
Amneal Pharmaceuticals Com Stk Cl A (AMRX) | 0.8 | $9.5M | 4.7M | 2.02 | |
Xenon Pharmaceuticals (XENE) | 0.8 | $9.4M | 260k | 36.10 | |
Guardant Health (GH) | 0.8 | $9.2M | 172k | 53.83 | |
Ionis Pharmaceuticals (IONS) | 0.8 | $8.9M | 202k | 44.23 | |
Liquidia Corporation Com New (LQDA) | 0.7 | $7.6M | 1.4M | 5.44 | |
Taro Pharmaceutical Inds SHS (TARO) | 0.6 | $6.7M | 223k | 29.98 | |
Gossamer Bio (GOSS) | 0.6 | $6.6M | 548k | 11.98 | |
Pliant Therapeutics (PLRX) | 0.5 | $6.1M | 294k | 20.89 | |
Merus N V (MRUS) | 0.5 | $5.5M | 277k | 20.03 | |
Maravai Lifesciences Hldgs I Com Cl A (MRVI) | 0.4 | $4.7M | 184k | 25.53 | |
Merck & Co Call Option (MRK) | 0.4 | $4.2M | 49k | 86.12 | |
Affimed Therapeutics B V | 0.3 | $3.9M | 1.9M | 2.06 | |
Aerie Pharmaceuticals | 0.3 | $3.9M | 256k | 15.13 | |
Puma Biotechnology (PBYI) | 0.3 | $3.6M | 1.5M | 2.37 | |
Vera Therapeutics Cl A (VERA) | 0.3 | $3.3M | 156k | 21.31 | |
Fate Therapeutics (FATE) | 0.3 | $3.2M | 142k | 22.41 | |
Point Biopharma Global | 0.3 | $3.2M | 410k | 7.73 | |
Agilent Technologies Inc C ommon (A) | 0.2 | $2.6M | 22k | 121.55 | |
908 Devices (MASS) | 0.2 | $2.2M | 131k | 16.45 | |
AMN Healthcare Services Put Option (AMN) | 0.2 | $2.0M | 19k | 105.96 | |
Icon SHS (ICLR) | 0.2 | $1.9M | 10k | 183.78 | |
Intuitive Surgical Com New (ISRG) | 0.1 | $1.7M | 9.1k | 187.44 | |
Xoma Corp Del Com New (XOMA) | 0.1 | $1.6M | 88k | 17.91 | |
Iqvia Holdings (IQV) | 0.1 | $1.5M | 8.3k | 181.14 | |
Laboratory Corp Amer Hldgs Com New | 0.1 | $1.5M | 7.2k | 204.81 | |
Avantor (AVTR) | 0.1 | $1.5M | 75k | 19.60 | |
Aadi Bioscience (AADI) | 0.1 | $1.4M | 102k | 14.13 | |
PerkinElmer (RVTY) | 0.1 | $1.3M | 11k | 120.33 | |
Argenx Se Sponsored Adr (ARGX) | 0.1 | $1.2M | 3.5k | 353.05 | |
Milestone Pharmaceuticals (MIST) | 0.1 | $1.2M | 127k | 9.19 | |
Repligen Corporation (RGEN) | 0.1 | $681k | 3.6k | 187.11 | |
Heska Corp Com Restrc New | 0.0 | $506k | 6.9k | 72.92 | |
Ac Immune Sa SHS (ACIU) | 0.0 | $394k | 125k | 3.16 | |
Cabaletta Bio (CABA) | 0.0 | $364k | 561k | 0.65 | |
Capital Sr Living Corp (SNDA) | 0.0 | $192k | 12k | 16.24 | |
Third Harmonic Bio Co (THRD) | 0.0 | $190k | 10k | 18.97 | |
Eledon Pharmaceuticals (ELDN) | 0.0 | $187k | 68k | 2.76 | |
Glycomimetics (GLYC) | 0.0 | $56k | 101k | 0.55 | |
Bolt Biotherapeutics (BOLT) | 0.0 | $46k | 31k | 1.48 |